ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Eagle Pharmaceuticals INC

Official 2024 U.S. DOL Form 5500 summary for Eagle Pharmaceuticals INC (Eagle Pharmaceuticals INC 401(k) Profit Sharing Plan & Trust · EIN 20-8179278 · PN 001): $16.47M net assets, 86 active participants, and $37.55 per $10,000 (37.55 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorEagle Pharmaceuticals INC
Filing IdentifierEagle Pharmaceuticals INC 401(k) Profit Sharing Plan & Trust · EIN 20-8179278 · PN 001
Plan Category & State401(k) Defined Contribution (NJ)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$16.47M
Active Participants86
Direct Admin Fee Rate$37.55 per $10,000 (37.55 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderBank of America / Merrill
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI